{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T12:36:40Z","timestamp":1794746200409,"version":"4.9.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":60,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The use of immunosuppressive therapies for rheumatoid arthritis (RA) is associated with substantial adverse effects. In addition, existing diagnostic reagents are limited in their ability to detect local joint damage. Here, we address both these needs using a collagen-hybridizing peptide (CHP) that selectively binds denatured collagen present in inflamed joints in RA models. Light-sheet scanning and immunohistology of the inflamed ankles in RA mice pre-injected with fluorescently-labeled-CHP revealed specific CHP accumulation within matrices of the synovial pannus and cartilage that express matrix metalloproteases and cathepsin K extensively. In vivo fluorescence probing with labeled CHP enabled dynamic monitoring of collagen breakdown throughout RA progression or regression with sensitivity beyond arthritis scoring. Moreover, bioconjugation of a therapeutic monoclonal antibody (mAb) against TNF with CHP enriched the mAb precisely within the pannus of inflamed joints in RA mice, resulting in improved efficacy relative to the native mAb and reduced systemic exposure. These findings highlight denatured collagen as a molecular matrix signature of RA lesions for diagnostic imaging and an effective target for RA drug delivery.<\/jats:p>","DOI":"10.1038\/s41467-026-72038-y","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T04:34:52Z","timestamp":1776659692000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Collagen hybridizing peptide imaging and delivery of therapeutic antibody in rheumatoid arthritis models"],"prefix":"10.1038","volume":"17","author":[{"given":"Xiaoyun","family":"Mo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjie","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haimin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junwen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suwen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xufei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuibo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4729-7860","authenticated-orcid":false,"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"key":"72038_CR1","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1016\/S0140-6736(23)01525-8","volume":"402","author":"A Di Matteo","year":"2023","unstructured":"Di Matteo, A., Bathon, J. M. & Emery, P. Rheumatoid arthritis. Lancet 402, 2019\u20132033 (2023).","journal-title":"Lancet"},{"key":"72038_CR2","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1038\/s41591-020-0939-8","volume":"26","author":"S Alivernini","year":"2020","unstructured":"Alivernini, S. et al. Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis. Nat. Med. 26, 1295\u20131306 (2020).","journal-title":"Nat. Med."},{"key":"72038_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41413-018-0016-9","volume":"6","author":"Q Guo","year":"2018","unstructured":"Guo, Q. et al. Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies. Bone Res. 6, 15 (2018).","journal-title":"Bone Res."},{"key":"72038_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2019.102392","volume":"110","author":"MAM van Delft","year":"2020","unstructured":"van Delft, M. A. M. & Huizinga, T. W. J. An overview of autoantibodies in rheumatoid arthritis. J. Autoimmun. 110, 102392 (2020).","journal-title":"J. Autoimmun."},{"key":"72038_CR5","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1093\/rheumatology\/ken052","volume":"47","author":"Z de Jong","year":"2008","unstructured":"de Jong, Z. et al. Value of serum cartilage oligomeric matrix protein as a prognostic marker of large-joint damage in rheumatoid arthritis-data from the RAPIT study. Rheumatology 47, 868\u2013871 (2008).","journal-title":"Rheumatology"},{"key":"72038_CR6","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s41584-020-00570-2","volume":"17","author":"CD Buckley","year":"2021","unstructured":"Buckley, C. D., Ospelt, C., Gay, S. & Midwood, K. S. Location, location, location: how the tissue microenvironment affects inflammation in RA. Nat. Rev. Rheumatol. 17, 195\u2013212 (2021).","journal-title":"Nat. Rev. Rheumatol."},{"key":"72038_CR7","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1136\/annrheumdis-2016-eular.5541","volume":"75","author":"T Ogura","year":"2016","unstructured":"Ogura, T. et al. SAT0561 finger joint cartilage evaluated by ultrasound and X-ray in rheumatoid arthritis and control joints. Ann. Rheum. Dis. 75, 872 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"72038_CR8","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1007\/s11547-019-01014-y","volume":"124","author":"M \u00d8stergaard","year":"2019","unstructured":"\u00d8stergaard, M. & Boesen, M. Imaging in rheumatoid arthritis: the role of magnetic resonance imaging and computed tomography. Radio. Med. 124, 1128\u20131141 (2019).","journal-title":"Radio. Med."},{"key":"72038_CR9","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/s41584-018-0079-4","volume":"14","author":"R Hardy","year":"2018","unstructured":"Hardy, R. & Cooper, M. S. Unravelling how glucocorticoids work in rheumatoid arthritis. Nat. Rev. Rheumatol. 14, 566\u2013567 (2018).","journal-title":"Nat. Rev. Rheumatol."},{"key":"72038_CR10","doi-asserted-by":"publisher","first-page":"e000536","DOI":"10.1136\/rmdopen-2017-000536","volume":"6","author":"C Hua","year":"2020","unstructured":"Hua, C., Buttgereit, F. & Combe, B. Glucocorticoids in rheumatoid arthritis: current status and future studies. RMD Open 6, e000536 (2020).","journal-title":"RMD Open"},{"key":"72038_CR11","doi-asserted-by":"crossref","unstructured":"Bijlsma, J. W. J. & Buttgereit, F. Adverse events of glucocorticoids during treatment of rheumatoid arthritis: lessons from cohort and registry studies. Rheumatology 55, ii3\u2013ii5 (2016).","DOI":"10.1093\/rheumatology\/kew344"},{"key":"72038_CR12","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrd3003","volume":"9","author":"TT Hansel","year":"2010","unstructured":"Hansel, T. T., Kropshofer, H., Singer, T., Mitchell, J. A. & George, A. J. T. The safety and side effects of monoclonal antibodies. Nat. Rev. Drug Discov. 9, 325\u2013338 (2010).","journal-title":"Nat. Rev. Drug Discov."},{"key":"72038_CR13","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/nrrheum.2009.279","volume":"6","author":"SY Kim","year":"2010","unstructured":"Kim, S. Y. & Solomon, D. H. Tumor necrosis factor blockade and the risk of viral infection. Nat. Rev. Rheumatol. 6, 165\u2013174 (2010).","journal-title":"Nat. Rev. Rheumatol."},{"key":"72038_CR14","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1002\/art.22504","volume":"56","author":"JR Curtis","year":"2007","unstructured":"Curtis, J. R. et al. Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor \u03b1 antagonists. Arthritis Rheum. 56, 1125\u20131133 (2007).","journal-title":"Arthritis Rheum."},{"key":"72038_CR15","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/bph.14516","volume":"176","author":"C Schultz","year":"2019","unstructured":"Schultz, C. Targeting the extracellular matrix for delivery of bioactive molecules to sites of arthritis. Br. J. Pharm. 176, 26\u201337 (2019).","journal-title":"Br. J. Pharm."},{"key":"72038_CR16","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1007\/s13346-018-0589-2","volume":"9","author":"DMSH Chandrupatla","year":"2019","unstructured":"Chandrupatla, D. M. S. H., Molthoff, C. F. M., Lammertsma, A. A., van der Laken, C. J. & Jansen, G. The folate receptor \u03b2 as a macrophage-mediated imaging and therapeutic target in rheumatoid arthritis. Drug Deliv. Transl. Res. 9, 366\u2013378 (2019).","journal-title":"Drug Deliv. Transl. Res."},{"key":"72038_CR17","doi-asserted-by":"publisher","first-page":"10092","DOI":"10.7150\/thno.44865","volume":"10","author":"H Wu","year":"2020","unstructured":"Wu, H. et al. Near-infrared fluorescence imaging-guided focused ultrasound-mediated therapy against Rheumatoid Arthritis by MTX-ICG-loaded iRGD-modified echogenic liposomes. Theranostics 10, 10092\u201310105 (2020).","journal-title":"Theranostics"},{"key":"72038_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107550","volume":"211","author":"N MacRitchie","year":"2020","unstructured":"MacRitchie, N. et al. Molecular imaging of inflammation-current and emerging technologies for diagnosis and treatment. Pharm. Ther. 211, 107550 (2020).","journal-title":"Pharm. Ther."},{"key":"72038_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/advs.201800397","volume":"5","author":"H Feng","year":"2018","unstructured":"Feng, H. et al. Rapid response fluorescence probe enabled in vivo diagnosis and assessing treatment response of hypochlorous acid-mediated rheumatoid arthritis. Adv. Sci. 5, 1800397 (2018).","journal-title":"Adv. Sci."},{"key":"72038_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202409661","volume":"36","author":"Y Zhang","year":"2024","unstructured":"Zhang, Y. et al. Microenvironment-activatable probe for precise NIR-II monitoring and synergistic immunotherapy in rheumatoid arthritis. Adv. Mater. 36, 2409661 (2024).","journal-title":"Adv. Mater."},{"key":"72038_CR21","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1021\/acsnano.3c09870","volume":"18","author":"Y Zhang","year":"2024","unstructured":"Zhang, Y. et al. Inflammation-responsive nanoagents for activatable photoacoustic molecular imaging and tandem therapies in rheumatoid arthritis. ACS Nano 18, 2231\u20132249 (2024).","journal-title":"ACS Nano"},{"key":"72038_CR22","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/art.38295","volume":"66","author":"NH Lim","year":"2014","unstructured":"Lim, N. H. et al. In vivo imaging of matrix metalloproteinase 12 and matrix metalloproteinase 13 activities in the mouse model of collagen-induced arthritis. Arthritis Rheumatol. 66, 589\u2013598 (2014).","journal-title":"Arthritis Rheumatol."},{"key":"72038_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2022.123584","volume":"247","author":"P Wu","year":"2022","unstructured":"Wu, P. & Xiong, H. An acid-enhanced OFF-ON fluorescent probe for the detection of hypochlorous acid in rheumatoid arthritis. Talanta 247, 123584 (2022).","journal-title":"Talanta"},{"key":"72038_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33526-z","volume":"13","author":"H Cho","year":"2022","unstructured":"Cho, H. et al. Visualizing inflammation with an M1 macrophage selective probe via GLUT1 as the gating target. Nat. Commun. 13, 5974 (2022).","journal-title":"Nat. Commun."},{"key":"72038_CR25","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aay1971","volume":"5","author":"K Katsumata","year":"2019","unstructured":"Katsumata, K. et al. Targeting inflammatory sites through collagen affinity enhances the therapeutic efficacy of anti-inflammatory antibodies. Sci. Adv. 5, eaay1971 (2019).","journal-title":"Sci. Adv."},{"key":"72038_CR26","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1186\/s13075-019-2075-8","volume":"21","author":"K Katsumata","year":"2019","unstructured":"Katsumata, K. et al. Conferring extracellular matrix affinity enhances local therapeutic efficacy of anti-TNF-\u03b1 antibody in a murine model of rheumatoid arthritis. Arthrit Res Ther. 21, 298 (2019).","journal-title":"Arthrit Res Ther."},{"key":"72038_CR27","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41584-022-00793-5","volume":"18","author":"N Komatsu","year":"2022","unstructured":"Komatsu, N. & Takayanagi, H. Mechanisms of joint destruction in rheumatoid arthritis - immune cell-fibroblast-bone interactions. Nat. Rev. Rheumatol. 18, 415\u2013429 (2022).","journal-title":"Nat. Rev. Rheumatol."},{"key":"72038_CR28","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.cll.2019.07.002","volume":"39","author":"H Allard-Chamard","year":"2019","unstructured":"Allard-Chamard, H. & Boire, G. Serologic diagnosis of rheumatoid arthritis. Clin. Lab Med 39, 525\u2013537 (2019).","journal-title":"Clin. Lab Med"},{"key":"72038_CR29","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/s41584-020-0413-5","volume":"16","author":"G Nygaard","year":"2020","unstructured":"Nygaard, G. & Firestein, G. S. Restoring synovial homeostasis in rheumatoid arthritis by targeting fibroblast-like synoviocytes. Nat. Rev. Rheumatol. 16, 316\u2013333 (2020).","journal-title":"Nat. Rev. Rheumatol."},{"key":"72038_CR30","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41584-023-00966-w","volume":"19","author":"B Grillet","year":"2023","unstructured":"Grillet, B. et al. Matrix metalloproteinases in arthritis: towards precision medicine. Nat. Rev. Rheumatol. 19, 363\u2013377 (2023).","journal-title":"Nat. Rev. Rheumatol."},{"key":"72038_CR31","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1002\/art.40527","volume":"70","author":"CF Kjelgaard-Petersen","year":"2018","unstructured":"Kjelgaard-Petersen, C. F. et al. Translational biomarkers and ex vivo models of joint tissues as a tool for drug development in rheumatoid arthritis. Arthritis Rheumatol. 70, 1419\u20131428 (2018).","journal-title":"Arthritis Rheumatol."},{"key":"72038_CR32","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1136\/ard.2010.135723","volume":"70","author":"D van Schaardenburg","year":"2010","unstructured":"van Schaardenburg, D. et al. Bone metabolism is altered in preclinical rheumatoid arthritis. Ann. Rheum. Dis. 70, 1173\u20131174 (2010).","journal-title":"Ann. Rheum. Dis."},{"key":"72038_CR33","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.clinbiochem.2011.01.001","volume":"44","author":"A-C Bay-Jensen","year":"2011","unstructured":"Bay-Jensen, A.-C. et al. Enzyme-linked immunosorbent assay (ELISAs) for metalloproteinase-derived type II collagen neoepitope, CIIM-increased serum CIIM in subjects with severe radiographic osteoarthritis. Clin. Biochem 44, 423\u2013429 (2011).","journal-title":"Clin. Biochem"},{"key":"72038_CR34","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1146\/annurev.biochem.77.032207.120833","volume":"78","author":"MD Shoulders","year":"2009","unstructured":"Shoulders, M. D. & Raines, R. T. Collagen structure and stability. Annu Rev. Biochem 78, 929\u2013958 (2009).","journal-title":"Annu Rev. Biochem"},{"key":"72038_CR35","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1042\/bj2470725","volume":"247","author":"CC Danielsen","year":"1987","unstructured":"Danielsen, C. C. Thermal stability of human-fibroblast-collagenase-cleavage products of type-I and type-III collagens. Biochem J. 247, 725\u2013729 (1987).","journal-title":"Biochem J."},{"key":"72038_CR36","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/nrm3904","volume":"15","author":"C Bonnans","year":"2014","unstructured":"Bonnans, C., Chou, J. & Werb, Z. Remodelling the extracellular matrix in development and disease. Nat. Rev. Mol. Cell Biol. 15, 786\u2013801 (2014).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"72038_CR37","doi-asserted-by":"publisher","first-page":"10901","DOI":"10.1021\/jacs.3c00713","volume":"145","author":"X Li","year":"2023","unstructured":"Li, X., Zhang, Q., Yu, S. M. & Li, Y. The chemistry and biology of collagen hybridization. J. Am. Chem. Soc. 145, 10901\u201310916 (2023).","journal-title":"J. Am. Chem. Soc."},{"key":"72038_CR38","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1038\/nprot.2006.393","volume":"1","author":"LM Khachigian","year":"2006","unstructured":"Khachigian, L. M. Collagen antibody-induced arthritis. Nat. Protoc. 1, 2512\u20132516 (2006).","journal-title":"Nat. Protoc."},{"key":"72038_CR39","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/s41422-018-0049-z","volume":"28","author":"D Jing","year":"2018","unstructured":"Jing, D. et al. Tissue clearing of both hard and soft tissue organs with the PEGASOS method. Cell Res. 28, 803\u2013818 (2018).","journal-title":"Cell Res."},{"key":"72038_CR40","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.mce.2010.04.005","volume":"335","author":"AE Coutinho","year":"2011","unstructured":"Coutinho, A. E. & Chapman, K. E. The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights. Mol. Cell Endocrinol. 335, 2\u201313 (2011).","journal-title":"Mol. Cell Endocrinol."},{"key":"72038_CR41","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/s41584-023-01043-y","volume":"19","author":"PC Taylor","year":"2023","unstructured":"Taylor, P. C. Are TNF inhibitors still the agent of choice for RA? Nat. Rev. Rheumatol. 19, 755\u2013756 (2023).","journal-title":"Nat. Rev. Rheumatol."},{"key":"72038_CR42","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41584-018-0109-2","volume":"15","author":"Z Chen","year":"2019","unstructured":"Chen, Z., Bozec, A., Ramming, A. & Schett, G. Anti-inflammatory and immune-regulatory cytokines in rheumatoid arthritis. Nat. Rev. Rheumatol. 15, 9\u201317 (2019).","journal-title":"Nat. Rev. Rheumatol."},{"key":"72038_CR43","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/s41584-022-00790-8","volume":"18","author":"M Kurowska-Stolarska","year":"2022","unstructured":"Kurowska-Stolarska, M. & Alivernini, S. Synovial tissue macrophages in joint homeostasis, rheumatoid arthritis and disease remission. Nat. Rev. Rheumatol. 18, 384\u2013397 (2022).","journal-title":"Nat. Rev. Rheumatol."},{"key":"72038_CR44","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1093\/rheumatology\/keh709","volume":"44","author":"A Wunder","year":"2005","unstructured":"Wunder, A., Straub, R. H., Gay, S. & Funk, J. M\u00fcller-Ladner U. Molecular imaging: novel tools in visualizing rheumatoid arthritis. Rheumatology 44, 1341\u20131349 (2005).","journal-title":"Rheumatology"},{"key":"72038_CR45","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/ncprheum0047","volume":"1","author":"U M\u00fcller-Ladner","year":"2005","unstructured":"M\u00fcller-Ladner, U., Pap, T., Gay, R. E., Neidhart, M. & Gay, S. Mechanisms of disease: the molecular and cellular basis of joint destruction in rheumatoid arthritis. Nat. Clin. Pr. Rheumatol. 1, 102\u2013110 (2005).","journal-title":"Nat. Clin. Pr. Rheumatol."},{"key":"72038_CR46","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1038\/s12276-022-00830-z","volume":"54","author":"W Won","year":"2022","unstructured":"Won, W. et al. Inhibiting peripheral and central MAO-B ameliorates joint inflammation and cognitive impairment in rheumatoid arthritis. Exp. Mol. Med. 54, 1188\u20131200 (2022).","journal-title":"Exp. Mol. Med."},{"key":"72038_CR47","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.3390\/molecules24162982","volume":"24","author":"L Rangasamy","year":"2019","unstructured":"Rangasamy, L. et al. Molecular imaging probes based on matrix metalloproteinase inhibitors (MMPIs). Molecules 24, 2982 (2019).","journal-title":"Molecules"},{"key":"72038_CR48","first-page":"2485","volume":"32","author":"RJ Wakefield","year":"2005","unstructured":"Wakefield, R. J. et al. Musculoskeletal ultrasound, including definitions for ultrasonographic pathology. J. Rheumatol. 32, 2485\u20132487 (2005).","journal-title":"J. Rheumatol."},{"key":"72038_CR49","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1097\/00002281-200207000-00013","volume":"14","author":"SR Goldring","year":"2002","unstructured":"Goldring, S. R. Pathogenesis of bone erosions in rheumatoid arthritis. Curr. Opin. Rheumatol. 14, 406\u2013410 (2002).","journal-title":"Curr. Opin. Rheumatol."},{"key":"72038_CR50","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jconrel.2017.06.013","volume":"261","author":"M Durymanov","year":"2017","unstructured":"Durymanov, M., Kamaletdinova, T., Lehmann, S. E. & Reineke, J. Exploiting passive nanomedicine accumulation at sites of enhanced vascular permeability for non-cancerous applications. J. Control. Release 261, 10\u201322 (2017).","journal-title":"J. Control. Release"},{"key":"72038_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/ar3089","volume":"12","author":"R Anderson","year":"2010","unstructured":"Anderson, R. et al. Liposomal encapsulation enhances and prolongs the anti-inflammatory effects of water-soluble dexamethasone phosphate in experimental adjuvant arthritis. Arthrit Res. Ther. 12, R147 (2010).","journal-title":"Arthrit Res. Ther."},{"key":"72038_CR52","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1056\/NEJMoa011110","volume":"345","author":"J Keane","year":"2001","unstructured":"Keane, J. et al. Tuberculosis associated with infliximab, a tumor necrosis factor \u03b1\u2013neutralizing agent. N. Engl. J. Med. 345, 1098\u20131104 (2001).","journal-title":"N. Engl. J. Med."},{"key":"72038_CR53","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.trecan.2025.05.003","volume":"11","author":"JL Chitty","year":"2025","unstructured":"Chitty, J. L. & Cox, T. R. The extracellular matrix in cancer: from understanding to targeting. Trends Cancer 11, 839\u2013849 (2025).","journal-title":"Trends Cancer"},{"key":"72038_CR54","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aay1041","volume":"12","author":"ML Cook Sangar","year":"2020","unstructured":"Cook Sangar, M. L. et al. A potent peptide-steroid conjugate accumulates in cartilage and reverses arthritis without evidence of systemic corticosteroid exposure. Sci. Transl. Med. 12, eaay1041 (2020).","journal-title":"Sci. Transl. Med."},{"key":"72038_CR55","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1002\/art.1780300108","volume":"30","author":"WJ Wallis","year":"1987","unstructured":"Wallis, W. J., Simkin, P. A. & Nelp, W. B. Protein traffic in human synovial effusions. Arthritis Rheum. 30, 57\u201363 (1987).","journal-title":"Arthritis Rheum."},{"key":"72038_CR56","doi-asserted-by":"publisher","first-page":"8171","DOI":"10.1002\/anie.200700700","volume":"46","author":"P Caravan","year":"2007","unstructured":"Caravan, P. et al. Collagen-targeted MRI contrast agent for molecular imaging of fibrosis. Angew. Chem. Int Ed. 46, 8171\u20138173 (2007).","journal-title":"Angew. Chem. Int Ed."},{"key":"72038_CR57","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1148\/radiol.2473070975","volume":"247","author":"PA Helm","year":"2008","unstructured":"Helm, P. A. et al. Postinfarction myocardial scarring in mice: molecular MR imaging with use of a collagen-targeting contrast agent. Radiology 247, 788\u2013796 (2008).","journal-title":"Radiology"},{"key":"72038_CR58","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaf4696","volume":"9","author":"P D\u00e9sog\u00e8re","year":"2017","unstructured":"D\u00e9sog\u00e8re, P. et al. Type I collagen\u2013targeted PET probe for pulmonary fibrosis detection and staging in preclinical models. Sci. Transl. Med 9, eaaf4696 (2017).","journal-title":"Sci. Transl. Med"},{"key":"72038_CR59","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1021\/acs.molpharmaceut.8b00982","volume":"16","author":"STG Bruijnen","year":"2019","unstructured":"Bruijnen, S. T. G. et al. F8-IL10: A new potential antirheumatic drug evaluated by a PET-guided translational approach. Mol. Pharm. 16, 273\u2013281 (2019).","journal-title":"Mol. Pharm."},{"key":"72038_CR60","first-page":"666","volume":"16","author":"M Galeazzi","year":"2014","unstructured":"Galeazzi, M. et al. A phase IB clinical trial with Dekavil (F8-IL10), an immunoregulatory \u2018armed antibody\u2019 for the treatment of rheumatoid arthritis, used in combination with methotrexate. Isr. Med. Assoc. J. 16, 666 (2014).","journal-title":"Isr. Med. Assoc. J."},{"key":"72038_CR61","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1021\/acs.bioconjchem.0c00324","volume":"31","author":"KJ Arlotta","year":"2020","unstructured":"Arlotta, K. J., San, B. H., Mu, H., Yu, S. M. & Owen, S. C. Localization of therapeutic Fab-CHP conjugates to sites of denatured collagen for the treatment of rheumatoid arthritis. Bioconj. Chem. 31, 1960\u20131970 (2020).","journal-title":"Bioconj. Chem."},{"key":"72038_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2025.115520","volume":"218","author":"G Raju","year":"2025","unstructured":"Raju, G. et al. Light sheet fluorescence microscopy for monitoring drug delivery: Unlocking the developmental phases of embryos. Adv. Drug Del. Rev. 218, 115520 (2025).","journal-title":"Adv. Drug Del. Rev."},{"key":"72038_CR63","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/s43018-023-00516-z","volume":"4","author":"S Zinn","year":"2023","unstructured":"Zinn, S. et al. Advances in antibody-based therapy in oncology. Nat. Cancer 4, 165\u2013180 (2023).","journal-title":"Nat. Cancer"},{"key":"72038_CR64","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/s41571-021-00588-9","volume":"19","author":"DJ Propper","year":"2022","unstructured":"Propper, D. J. & Balkwill, F. R. Harnessing cytokines and chemokines for cancer therapy. Nat. Rev. Clin. Oncol. 19, 237\u2013253 (2022).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"72038_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54081-9","volume":"15","author":"C Mao","year":"2024","unstructured":"Mao, C. et al. In situ editing of tumour cell membranes induces aggregation and capture of PD-L1 membrane proteins for enhanced cancer immunotherapy. Nat. Commun. 15, 9723 (2024).","journal-title":"Nat. Commun."},{"key":"72038_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18794-x","volume":"11","author":"J Winkler","year":"2020","unstructured":"Winkler, J., Abisoye-Ogunniyan, A., Metcalf, K. J. & Werb, Z. Concepts of extracellular matrix remodelling in tumour progression and metastasis. Nat. Commun. 11, 5120 (2020).","journal-title":"Nat. Commun."},{"key":"72038_CR67","doi-asserted-by":"publisher","first-page":"19138","DOI":"10.1021\/acsnano.1c07112","volume":"15","author":"L Liu","year":"2021","unstructured":"Liu, L. et al. Molecular imaging of collagen destruction of the spine. ACS Nano 15, 19138\u201319149 (2021).","journal-title":"ACS Nano"},{"key":"72038_CR68","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202003399","volume":"32","author":"J Chen","year":"2020","unstructured":"Chen, J. et al. Tocilizumab\u2013conjugated polymer nanoparticles for NIR-II photoacoustic-imaging-guided therapy of rheumatoid arthritis. Adv. Mater. 32, e2003399 (2020).","journal-title":"Adv. Mater."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72038-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72038-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72038-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:02:40Z","timestamp":1781827360000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72038-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["72038"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-72038-y","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"assertion":[{"value":"29 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5423"}}